Department of Pathology, Rush University Medical Center, Chicago, IL 60612, USA.
Am J Surg Pathol. 2010 Jul;34(7):935-41. doi: 10.1097/PAS.0b013e3181ddf52f.
A rare variant of hepatocellular carcinoma (HCC) is encountered that produces small cirrhosis-like nodules diffusely throughout the liver (CL-HCC), instead of a larger evident mass. This pattern remains undetected as carcinoma clinically and radiographically and is unexpectedly discovered after liver transplantation in the explanted native liver. We studied 10 such cases (9 males and 1 female, age 35 to 80 y) from 4 medical centers. The pretransplant clinical, laboratory, and radiographical studies were reviewed to determine the cause and stage of liver disease, alpha-fetoprotein (AFP) levels, and detectability of a mass on imaging. All 10 cases had underlying cirrhosis of varying etiology [3 hepatitis C virus (HCV), 3 alcoholic hepatitis, 1 hepatitis B virus, 1 autoimmune, and 2 mixed HCV/alcoholic hepatitis and hemochromatosis/HCV] and underwent orthotopic liver transplantation with no preoperative clinical suspicion of HCC. Ultrasound and/or dynamic imaging showed cirrhosis and no definite HCC. AFP levels were only mildly elevated in only 3 of 10 cases (144, 150, and 252 ng/mL). Grossly, there were innumerable (from about 20 to >1000) small CL-HCC nodules (0.2 to 0.6 cm) scattered among cirrhotic nodules. Histologically, these were well or moderately differentiated HCC, often with pseudoglandular pattern, perinodular sclerotic rims, cholestasis, frequent Mallory bodies, and small vessel invasion. In addition to the usual HCC immunophenotype, CL-HCC showed frequent ubiquitin and cytoplasmic and membranous CD10 positivity, relatively low Ki-67 proliferative index and absence of AFP immunohistochemically. CL-HCC warrants recognition as a unique HCC variant that evades pretransplant detection despite massive tumor burden, mimics cirrhotic nodules, and shows some uncommon pathologic and immunophenotypical characteristics.
弥漫性小结节性肝细胞癌的一种罕见变异型,其特点为肝脏内弥漫性分布小结节,类似于小结节性肝硬化,而非较大的明显肿块。这种表现临床上和影像学上均无法识别为癌,且在肝移植时于供肝中意外发现。我们研究了来自 4 个医学中心的 10 例此类病例(9 名男性,1 名女性;年龄 35 至 80 岁)。回顾分析了患者的移植前临床、实验室和影像学检查资料,以明确肝病的病因和分期、甲胎蛋白(AFP)水平,以及影像学上能否发现肿块。所有 10 例患者均存在不同病因所致的基础肝硬化[3 例丙型肝炎病毒(HCV)、3 例酒精性肝炎、1 例乙型肝炎病毒、1 例自身免疫性疾病和 2 例 HCV/酒精性肝炎合并血色病/HCV],并接受了原位肝移植,术前无 HCC 的临床怀疑。超声和/或动态成像显示肝硬化,无明确 HCC。10 例患者中仅 3 例 AFP 轻度升高(分别为 144、150 和 252ng/ml)。大体上,肝脏内可见无数(约 20 至>1000 个)直径 0.2 至 0.6cm 的小结节性肝硬化伴弥漫性肝细胞癌(CL-HCC)结节。组织学上,这些为分化良好或中等分化 HCC,常呈假腺管样结构,伴结节周围硬化性边缘、胆汁淤积、Mallory 小体多见、小血管侵犯。CL-HCC 除了具有 HCC 的常见免疫表型外,还常表现为泛素和细胞质及膜 CD10 阳性,Ki-67 增殖指数相对较低,免疫组化法不表达 AFP。CL-HCC 是一种独特的 HCC 变异型,尽管肿瘤负荷巨大,但仍可逃避移植前检测,其表现类似小结节性肝硬化,且具有一些不常见的病理和免疫表型特征。